FDC receives EIR for Aurangabad facility

FDC has received an Establishment Inspection Report (EIR) for its manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which was inspected from August 10, 2018 to August 16, 2018 by US Food and Drug Administration (USFDA).

The facility is considered to be acceptable with regards to current Good Manufacturing Practices (GMPs) and the inspection stands closed.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

LPG Users Alert: Complete eKYC by August 16 Magic Photo Editor drops ₹12,579 before Pixel 11 launch! Jio’s Best Offer: Free WiFi for 1 Month, 100Mbps Internet!